<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Rouse Kidd | Activity</title>
	<link>https://www.catswannabecats.com/members/lilachate6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/lilachate6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Rouse Kidd.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">33ac3d6383f71277cfcbfee6cf3443d2</guid>
				<title>Rouse Kidd posted an update: Finally, IXA and BTZ exhibited anti-leukemic effects for [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12507/</link>
				<pubDate>Sun, 01 Jun 2025 10:59:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>Finally, IXA and BTZ exhibited anti-leukemic effects for primary ex vivo ALL and AML cells; mean LC50 (nM) for IXA 24 ± 11 and 30 ± 8, respectively, and mean LC50 for BTZ 4.5 ± 1 and 11 ± 4, respectively. IXA has overlapping mechanisms of action with BTZ and showed anti-leukemic activity in primary leukemic cells, encouraging further pre&hellip;<span class="activity-read-more" id="activity-read-more-12507"><a href="https://www.catswannabecats.com/activity/p/12507/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f730c9ef8f121b787457c66212d3e17b</guid>
				<title>Rouse Kidd posted an update: Meanwhile, the mechanical properties were also improved via [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2503/</link>
				<pubDate>Sat, 31 May 2025 08:22:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>Meanwhile, the mechanical properties were also improved via the second phase strengthening. Both Mg-1Zn-1Sn and Mg-1Zn-1Sn-0.2Sr alloys showed excellent biocompatibility, significantly promoted cell proliferation, adhesion and spreading. Particularly, significant increases in ALP activity, ARS staining, type I collagen (COL-I) expression as well&hellip;<span class="activity-read-more" id="activity-read-more-2503"><a href="https://www.catswannabecats.com/activity/p/2503/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f0297d755c5cf98dc43585e381282ebe</guid>
				<title>Rouse Kidd became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/2324/</link>
				<pubDate>Sat, 31 May 2025 08:08:23 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>